Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05660967 |
| Title | Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma (EPCORE DLBCL-3) |
| Acronym | EPCORE DLBCL-3 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Genmab |
| Indications | |
| Therapies | |
| Age Groups: | senior |
| Covered Countries | USA | POL | ITA | GBR | FRA | ESP | DEU | CZE | BEL | AUT |